Kytopen
Biotechnology · Cell & Gene Therapy
Sponsors visas
6EmployeesUS Form 5500 (plan participants) · Dec 2025 · -54% in a year
Facts
as of Nov 17, 2026Kytopen is accelerating access to the next generation of cell therapies through scalable genome engineering by solving manufacturing problems at discovery.
- Legal name
- Kytopen Corp.
- Headquarters
- Cambridge, United States
- Founded
- 2017
- Employees
- 6US Form 5500 (plan participants) · Dec 2025 · -54% in a year
- Register numbers
- NAME kytopen corp
- Official records
- SEC CIK 1777277
- Website
- kytopen.com
These are the key facts about Kytopen on Alion as of Nov 17, 2026. Kytopen is headquartered in Cambridge, United States. It was founded in 2017. It has raised $52.7M in 5 funding rounds. The latest round is Venture - Series Unknown of $7.1M, announced in 2025.
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
What the registers and the postings say about this employer.
Legal entity active
Kytopen Corp.
Not checked
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Visa
Full chapter →Named in the work visa registers of United States.
0H-1B filings in 12 months
0Open roles in United States
In the register as Kytopen Corp, Cambridge, MA
Other sponsors in the same field
Alert me
US Department of Labor · latest filing Dec 26, 2024
Footprint
Hiring in 1 city in 1 country.
1Cities
1Countries
| Site | Type | Open roles | Hires most for | Engineering |
|---|---|---|---|---|
| Cambridge United States | Headquarters | 0 |
Source: office addresses in postings and company registers
Financials
Funding rounds, investors and revenue on record.
$52.7MTotal raised
$3.1MPublic grants4 public grants
Venture - Series UnknownLatest round
9Rounds and grants
Money by yearUSD, rounds and grants
Largest rounds and grants
2021
$32.5M
$7.1M
2024
$5.7M
$4.4M
$3.1M
Sources: funding announcements, grant and company registers
Milestones
2025
Team shrank to 6 was 13 · US Form 5500 (plan participants)
May 8, 2025
Apr 28, 2025
Feb 6, 2025
Raised a round Venture round $7.1M · SEC Form D
Aug 8, 2024
Won a grant $1.6M · CORDIS
Jan 5, 2023
2017
Founded
Each milestone is dated by its source: registers, filings, the press
Newsroom
Apr 292026
News · YahooFinance
Kytopen Corp., a leader in non-viral, continuous flow cellular engineering technologies, T-CURX GmbH ("T-CURX"), a leader in transposon-based CAR-T manufacturing, and Fraunhofer…
Apr 102026
News · Pulse 2.0
Kytopen announced a Series B financing round led by Telegraph Hill Partners, with participation from existing investors, as the company accelerates commercialization of its cellu…
Nov 12, 20252025
News · YahooFinance
Kytopen Corp., a leader in continuous flow cellular engineering, and Excellos, Inc., a cell therapy CDMO and member of Blood Centers of America (BCA), today announced that the tw…
May 8, 20252025
News · YahooFinance
Kytopen Corp., a leader in providing continuous flow cellular engineering technologies and Bio-Techne Corporation (NASDAQ: TECH), a leading provider of innovative life science re…
Apr 29, 20252025
News · YahooFinance
Kytopen Corp., a leader in providing non-viral, continuous flow cellular engineering technologies and Aldevron, a leading global manufacturer serving organizations in the gene ed…
Apr 28, 20252025
News · Nasdaq
(RTTNews) - Kytopen Corp., and Aldevron, a subsidiary of Danaher Corp. (DHR), Tuesday announced a collaboration to improve the workflow solutions for cell therapy manufacturers,…
Sources: the outlets named on each headline, each story once
